Recently, blood centers began investigational testing for HIV RNA by pooled
nucleic acid testing (NAT). A 35-year-old frequent platelet donor tested H
IV p24 antigen positive, antibody negative before implementation of NAT He
made 2 platelet donations (day -4 and -11) immediately before testing posit
ive for HIV The donor's HIV seroconversion was monitored, and stored sample
s were tested retrospectively for HIV RNA. Platelet recipients were tested
for HIV infection. The day -4 sample tested positive for HIV RNA by pooled
and individual sample NAT The day -11 sample tested negative for HIV RNA by
both NAT tests. The 2 recipients of the day -4 platelets tested HIV RNA an
d p24 antigen positive. The recipient of the day -11 platelets could not be
tested because he had died. HIV NAT would have prevented transmission of H
IV had it been available at the time of this donor's HIV seroconversion.